Back to results
US 7,605,131 B2Granted
EML4-ALK fusion gene
AssigneesAstellas Pharma Inc., CureGene K.K.
InventorsHiroyuki Mano, Sadao Kuromitsu, Nobuaki Shindo, Takatoshi Soga, Takashi Furutani
Life of this patent
Estimating the term…
Abstract
The present inventors found that a fusion gene present in some cancer patients is an oncogene. The present invention relates to a polypeptide as a novel fusion protein, a polynucleotide encoding the polypeptide, a vector comprising the polynucleotide, a transformed cell comprising the vector, and a therapeutic agent for cancer.
Claims4
An isolated polynucleotide encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:
- 1.
Dependencies are inferred from the claim text.